Sunshine Coast commuters can expect “minor delays” through Selma Park from April 15 to May 15 as Hazelwood Construction completes the final phase of the road work in the area. As such ...

The company has launched its Phase I/IIa clinical trial to evaluate the safety and pharmacokinetic profile of CMND-100, a treatment for Alcohol Use Disorder (AUD), with trials taking place in the ...

On Monday, Verve Therapeutics (NASDAQ: VERV), a $366 million market cap biotech company whose shares have surged nearly 39% in the past week, showcased promising data from its Phase Ib Heart-2 ...

SAN DIEGO - Ensysce Biosciences Inc. (NASDAQ:ENSC), currently trading at $1.96 and showing signs of being undervalued according to InvestingPro Fair Value metrics, has concluded Part 1 of its second ...

It is hard enough to deal with Diego Lopes when the blitzing Brazilian is firing a flurry of punches. But with compromised vision? UFC 315: Muhammad v Della Maddalena | SUN 11 MAY | The UFC’s ...

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

On Monday, Verve Therapeutics (NASDAQ: VERV), a $366 million market cap biotech company whose shares have surged nearly 39% in the past week, showcased promising data from its Phase Ib Heart-2 trial, ...

TORONTO - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL), a clinical-stage life sciences company with a market capitalization of $87 million, has initiated a pivotal Phase III trial at ...

VANCOUVER - Clearmind Medicine Inc. (NASDAQ:CMND), a biotech firm specializing in the development of psychedelic-derived therapeutics with a current market capitalization of $4.72 million, has ...